Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-10-04 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-058930 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-04 | 2021-10-01 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $58.83 | -50.0K | 141.7K | -26% | -$2.94M |
| D | 2021-10-04 | 2021-10-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +50.0K | 158.0K | +46% | +$327.5K |
| D | 2021-10-04 | 2021-10-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $0.00 | -50.0K | 116.6K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | S | D | 21,844 | $58.96 | 119,892 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $58.45 to $59.44 per share. |
| 2 | Common | Common Stock | 2021-10-01 | M | A | 50,000 | $6.55 | 158,048 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-01 | S | D | 11,844 | $59.68 | 108,048 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $59.45 to $60.07 per share. |
| 4 | Common | Common Stock | 2021-10-01 | S | D | 16,312 | $58.03 | 141,736 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $57.41 to $58.36 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 4. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-10-01 | M | D | 50,000 | $0.00 | 116,643 | D | $6.55 · — to 2028-01-16 | 50,000 Common Stock | (F5) This option is fully vested. |